Buy LuciRevu 110mg Tablet (Revumenib) Online in Pakistan | Uses, Benefits & Price

For patients diagnosed with certain forms of acute leukemia, access to the right targeted treatment can make an important difference in their treatment journey. LuciRevu 110mg Tablet (Revumenib) is a prescription targeted therapy that contains Revumenib, a menin inhibitor developed for specific types of relapsed or refractory acute leukemia identified through molecular testing.

Unlike conventional chemotherapy, Revumenib works by targeting the menin protein, which plays a key role in the growth of leukemia cells carrying specific genetic abnormalities. Because this treatment is designed for selected patients, doctors first confirm the required genetic changes before prescribing the medicine.

At MedicineWalyDost, we understand how important it is for patients and caregivers to receive genuine imported oncology medicines from a trusted source. We focus on authentic products, careful handling, secure packaging, and reliable delivery across Pakistan.

Whether you are searching for the LuciRevu 110mg Tablet Price in Pakistan, checking availability, or looking for reliable information before placing an order, our team is available to assist you.

Important: LuciRevu 110mg Tablet (Revumenib) is a prescription-only medicine and should only be used under the supervision of a qualified hematologist or oncologist.

Product Information

What is LuciRevu 110mg Tablet (Revumenib)?

LuciRevu 110mg Tablet contains Revumenib, a targeted anticancer medicine that belongs to a new class of medicines known as menin inhibitors. It is prescribed for selected patients with relapsed or refractory acute leukemia after appropriate genetic testing confirms eligibility.

Revumenib works differently from standard chemotherapy. Instead of attacking rapidly dividing cells in general, it blocks the interaction between menin and specific leukemia-driving genetic changes, helping reduce the growth and survival of abnormal blood cells. This precision-based approach allows treatment to be tailored to patients whose leukemia matches the approved molecular profile.

Medical Uses of LuciRevu 110mg Tablet

Your specialist may prescribe LuciRevu 110mg Tablet (Revumenib) for eligible patients with:

• Relapsed or refractory acute leukemia with a KMT2A translocation.
• Relapsed or refractory acute myeloid leukemia (AML) with an eligible NPM1 mutation, when appropriate and no satisfactory alternative treatment options are available.

Treatment suitability depends on laboratory testing, medical history, previous therapies, and the clinical judgment of your treating specialist.

Why Do Doctors Prescribe Revumenib?

Doctors prescribe Revumenib because it is designed to target a specific disease mechanism rather than using a one-size-fits-all approach.

Potential clinical advantages include:

• Precision treatment based on genetic testing.
• Targets leukemia cells through menin inhibition.
• Oral tablet for convenient administration.
• May become part of an individualized treatment plan for eligible patients.
• Used under specialist supervision with regular monitoring.

How Does LuciRevu 110mg Tablet (Revumenib) Work?

LuciRevu 110mg Tablet contains Revumenib, a targeted cancer medicine that belongs to a newer class of treatments called menin inhibitors.

In certain types of acute leukemia, changes in genes such as KMT2A or NPM1 can cause leukemia cells to continue growing uncontrollably. Revumenib works by blocking the interaction between the menin protein and these abnormal genetic pathways. This helps interrupt the signals that leukemia cells depend on for survival and growth.

Unlike traditional chemotherapy, Revumenib is designed to target a specific disease mechanism. Because of this precision approach, treatment is only suitable for patients whose leukemia has been confirmed through appropriate molecular testing.

Medical Uses of LuciRevu 110mg Tablet

Your hematologist or oncologist may prescribe LuciRevu 110mg Tablet (Revumenib) for eligible patients with:

• Relapsed or refractory acute leukemia with a KMT2A translocation.
• Relapsed or refractory acute myeloid leukemia (AML) with an eligible NPM1 mutation, when appropriate.

Before starting treatment, doctors perform genetic testing to confirm whether Revumenib is the right targeted therapy for the patient.

Benefits of LuciRevu 110mg Tablet

When prescribed for the right patient, LuciRevu 110mg Tablet may provide several important treatment advantages.

Potential Benefits

• Specifically targets leukemia cells with eligible genetic mutations.
• Helps interrupt disease-driving molecular pathways.
• Supports a personalized treatment approach based on genetic testing.
• Available as an oral tablet for convenient administration.
• May help manage relapsed or refractory leukemia as part of a specialist-directed treatment plan.

Treatment outcomes vary from patient to patient, and regular medical monitoring is essential throughout therapy.

How to Take LuciRevu 110mg Tablet

Always take LuciRevu 110mg Tablet exactly as prescribed by your treating specialist.

For best results:

• Take the medicine at the same times each day.
• Swallow the tablet whole with water.
• Follow your doctor’s instructions regarding food and dosing schedule.
• Never change the prescribed dose without medical advice.
• Do not stop treatment unless your healthcare provider instructs you to do so.

If you miss a dose, follow the instructions provided by your doctor or the official patient information. Never take a double dose to make up for a missed one.

Possible Side Effects of LuciRevu 110mg Tablet

Like all prescription medicines, Revumenib can cause side effects. Some are mild, while others require immediate medical attention.

Common Side Effects

Some patients may experience:

• Nausea
• Diarrhea
• Constipation
• Tiredness or fatigue
• Muscle or bone pain
• Swelling (edema)
• Reduced appetite
• Mild changes in blood test results, including liver enzymes or electrolytes

Your healthcare team will monitor these effects during treatment.

Serious Warnings – Contact Your Doctor Immediately

Revumenib carries important safety warnings. Seek urgent medical attention if you develop:

• Signs of differentiation syndrome, such as fever, breathing difficulty, rapid weight gain, swelling, low blood pressure, or reduced urine output.
• Fast, slow, or irregular heartbeat.
• Fainting or severe dizziness.
• Severe infection or persistent fever.
• Unusual bleeding or bruising.
• Yellowing of the skin or eyes (possible liver problems).

Important Warnings & Precautions

Before taking LuciRevu 110mg Tablet (Revumenib), inform your doctor if you:

• Have heart rhythm problems or a history of QT prolongation.
• Have liver disease.
• Have electrolyte imbalances, such as low potassium or magnesium.
• Are pregnant, planning pregnancy, or breastfeeding.
• Are taking prescription medicines, herbal products, or supplements.

Your doctor may recommend:

• Regular ECG monitoring.
• Blood tests to check liver function and electrolyte levels.
• Routine follow-up visits to monitor your response to treatment.

LuciRevu 110mg Tablet Price in Pakistan

The LuciRevu 110mg Tablet Price in Pakistan may vary depending on import availability, supplier pricing, exchange rates, and market conditions. As an imported targeted oncology medicine, its price can change based on international supply and stock availability.

To get the latest LuciRevu 110mg Tablet price in Pakistan, contact MedicineWalyDost. Our team can provide updated pricing, confirm stock availability, and assist you with the ordering process.

Note: Product prices are subject to change without prior notice based on supplier and import updates.

Buy LuciRevu 110mg Tablet (Revumenib) Online in Pakistan

If your hematologist or oncologist has prescribed LuciRevu 110mg Tablet (Revumenib), choosing a trusted supplier is essential to ensure you receive a genuine medicine stored and handled according to pharmaceutical standards.

At MedicineWalyDost, we supply authentic imported oncology medicines sourced from reliable pharmaceutical suppliers. Every order is carefully packed to help maintain product quality during delivery.

Whether you are purchasing for yourself or a family member, our support team is available to assist with product availability, pricing, and delivery across Pakistan.

Prescription Required: LuciRevu 110mg Tablet should only be purchased and used with a valid prescription issued by a qualified hematologist or oncologist.

Why Choose MedicineWalyDost?

Patients and caregivers need more than just a medicine—they need confidence that they are receiving an authentic product from a trusted supplier.

Why Customers Choose Us

• Genuine imported oncology medicines.
• Reliable sourcing from trusted pharmaceutical suppliers.
• Secure packaging to protect medicine quality.
• Delivery service available across Pakistan.
• Assistance with stock confirmation and ordering.
• Responsive customer support.
• Commitment to quality, authenticity, and patient care.

Our goal is to help patients access specialty medicines safely, conveniently, and with complete confidence.

Storage Instructions

To maintain the quality of LuciRevu 110mg Tablet (Revumenib):

• Store the tablets according to the manufacturer’s storage instructions.
• Keep the medicine in its original packaging until use.
• Protect it from excessive heat, moisture, and direct sunlight.
• Keep out of the reach of children and pets.
• Do not use the medicine after the expiry date printed on the packaging.

Always consult your pharmacist if you have any questions about proper storage.

Important Safety Information

For safe treatment with LuciRevu 110mg Tablet:

• Take the medicine exactly as prescribed by your specialist.
• Attend all scheduled follow-up appointments.
• Complete all recommended blood tests, ECGs, and laboratory monitoring.
• Inform your doctor immediately if you experience symptoms such as fever, breathing difficulty, rapid weight gain, irregular heartbeat, severe dizziness, or signs of infection.
• Tell your healthcare provider about all prescription medicines, vitamins, and herbal supplements you are taking to reduce the risk of drug interactions.

Careful monitoring throughout treatment helps your healthcare team manage side effects and evaluate your response to therapy.

Order Genuine LuciRevu 110mg Tablet from MedicineWalyDost

Looking for LuciRevu 110mg Tablet (Revumenib) in Pakistan?

MedicineWalyDost provides genuine imported oncology medicines with secure packaging and reliable nationwide delivery. Contact our team today to check the latest LuciRevu 110mg Tablet Price in Pakistan, confirm product availability, and receive professional assistance with your order.

Frequently Asked Questions (FAQs)

1. What is LuciRevu 110mg Tablet (Revumenib) used for?

LuciRevu 110mg Tablet contains Revumenib, a prescription targeted therapy used to treat certain types of relapsed or refractory acute leukemia in eligible patients. Your doctor will determine if this medicine is appropriate based on genetic testing and your medical condition.

2. How does LuciRevu 110mg Tablet work?

LuciRevu contains Revumenib, a menin inhibitor that blocks the interaction between the menin protein and specific genetic changes that help leukemia cells grow. By targeting this pathway, the medicine helps slow the growth of leukemia cells in eligible patients.

3. Who can take LuciRevu 110mg Tablet?

This medicine is intended for patients whose leukemia matches the approved genetic criteria, such as certain KMT2A rearrangements or eligible NPM1 mutations, as determined by their treating specialist. It should only be used under the supervision of a qualified hematologist or oncologist.

4. Is genetic testing required before starting Revumenib?

Yes. Genetic testing is an essential part of treatment planning because Revumenib is designed for patients with specific genetic changes. Your doctor will confirm whether your leukemia is suitable for this targeted therapy before prescribing it.

5. How should I take LuciRevu 110mg Tablet?

Take LuciRevu 110mg Tablet exactly as prescribed by your healthcare provider. Swallow the tablet whole with water and follow your doctor’s dosing instructions carefully. Never change the dose or stop treatment without medical advice.

6. What are the common side effects of LuciRevu 110mg Tablet?

Some patients may experience:

• Nausea
• Diarrhea or constipation
• Tiredness
• Muscle or bone pain
• Swelling (edema)
• Reduced appetite
• Changes in blood test results

Your healthcare team will monitor you regularly during treatment.

7. What serious side effects should I report immediately?

Contact your doctor immediately if you develop:

• Fever or signs of infection.
• Difficulty breathing.
• Rapid weight gain or swelling.
• Irregular heartbeat or fainting.
• Severe dizziness.
• Yellowing of the skin or eyes.
• Unusual bleeding or bruising.

These symptoms require prompt medical evaluation.

8. Can LuciRevu 110mg Tablet interact with other medicines?

Yes. Revumenib may interact with certain prescription medicines, herbal supplements, and over-the-counter products. Always inform your doctor about all medicines and supplements you are taking before starting treatment.

9. What is the LuciRevu 110mg Tablet Price in Pakistan?

The LuciRevu 110mg Tablet Price in Pakistan may vary depending on import availability and supplier pricing. For the latest price and stock information, contact MedicineWalyDost directly.

10. Where can I buy LuciRevu 110mg Tablet (Revumenib) online in Pakistan?

You can order LuciRevu 110mg Tablet (Revumenib) from MedicineWalyDost, a trusted supplier of genuine imported oncology medicines in Pakistan. A valid prescription is required before purchase.

11. How should LuciRevu 110mg Tablet be stored?

Store the tablets according to the manufacturer’s instructions, in their original packaging, away from excessive heat, moisture, and direct sunlight. Keep the medicine out of the reach of children.

12. Why is LuciRevu 110mg Tablet considered a targeted therapy?

Unlike traditional chemotherapy, Revumenib specifically targets the menin pathway, which plays an important role in certain genetically defined leukemias. This targeted approach allows treatment to focus on the disease mechanism while being used only in patients who meet the approved genetic criteria.